These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 19738069)
1. Role of cyclic AMP response element-binding protein in insulin-like growth factor-i receptor up-regulation by sex steroids in prostate cancer cells. Genua M; Pandini G; Sisci D; Castoria G; Maggiolini M; Vigneri R; Belfiore A Cancer Res; 2009 Sep; 69(18):7270-7. PubMed ID: 19738069 [TBL] [Abstract][Full Text] [Related]
2. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells. Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736 [TBL] [Abstract][Full Text] [Related]
3. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383 [TBL] [Abstract][Full Text] [Related]
4. Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling. Malaguarnera R; Sacco A; Morcavallo A; Squatrito S; Migliaccio A; Morrione A; Maggiolini M; Belfiore A Endocrinology; 2014 Apr; 155(4):1207-21. PubMed ID: 24437490 [TBL] [Abstract][Full Text] [Related]
5. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214 [TBL] [Abstract][Full Text] [Related]
6. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
7. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway. Pandini G; Genua M; Frasca F; Vigneri R; Belfiore A Ann N Y Acad Sci; 2009 Feb; 1155():263-7. PubMed ID: 19250214 [TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1. Maor S; Mayer D; Yarden RI; Lee AV; Sarfstein R; Werner H; Papa MZ J Endocrinol; 2006 Dec; 191(3):605-12. PubMed ID: 17170218 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909 [TBL] [Abstract][Full Text] [Related]
10. Autocrine activation of the local insulin-like growth factor I system is up-regulated by estrogen receptor (ER)-independent estrogen actions and accounts for decreased ER expression in type 2 diabetic mesangial cells. Karl M; Potier M; Schulman IH; Rivera A; Werner H; Fornoni A; Elliot SJ Endocrinology; 2005 Feb; 146(2):889-900. PubMed ID: 15550505 [TBL] [Abstract][Full Text] [Related]
11. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Song RX; Zhang Z; Chen Y; Bao Y; Santen RJ Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128 [TBL] [Abstract][Full Text] [Related]
12. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. Dai JL; Burnstein KL Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells. Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells. Schayek H; Seti H; Greenberg NM; Sun S; Werner H; Plymate SR Mol Cell Endocrinol; 2010 Jul; 323(2):239-45. PubMed ID: 20417685 [TBL] [Abstract][Full Text] [Related]
15. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line. Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895 [TBL] [Abstract][Full Text] [Related]
17. Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model. Krueckl SL; Sikes RA; Edlund NM; Bell RH; Hurtado-Coll A; Fazli L; Gleave ME; Cox ME Cancer Res; 2004 Dec; 64(23):8620-9. PubMed ID: 15574769 [TBL] [Abstract][Full Text] [Related]
18. In vivo progression of LAPC-9 and LNCaP prostate cancer models to androgen independence is associated with increased expression of insulin-like growth factor I (IGF-I) and IGF-I receptor (IGF-IR). Nickerson T; Chang F; Lorimer D; Smeekens SP; Sawyers CL; Pollak M Cancer Res; 2001 Aug; 61(16):6276-80. PubMed ID: 11507082 [TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner. Schayek H; Haugk K; Sun S; True LD; Plymate SR; Werner H Clin Cancer Res; 2009 Mar; 15(5):1558-65. PubMed ID: 19223505 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor. Knowlden JM; Hutcheson IR; Barrow D; Gee JM; Nicholson RI Endocrinology; 2005 Nov; 146(11):4609-18. PubMed ID: 16037379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]